Sign In |Help & Support
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)

Chemical Evaluation of Medical Devices

Chemical Evaluation of Medical Devices, Total:388 items.

The international standard classification for "Chemical Evaluation of Medical Devices" includes: Medical equipment in general , Laboratory medicine , Dental materials , Surgical instruments and materials , Sterilization and disinfection in general , Other medical equipment .

The Chinese standard classification for "Chemical Evaluation of Medical Devices" includes: Medical apparatus and devices in general , Stomatologic device, equipment and material , Public medical equipment .


未注明发布机构

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

  • GB/T 16886.5-2017 Biological evaluation of medical devices―Part 5:Tests for in vitro cytotoxicity
  • GB/T 16886.11-1997 Biological evaluation of medical devices--Part 11: Tests for systemic toxicity
  • GB/T 16886.11-2011 Biological evaluation of medical devices—Part 11:Tests for systemic toxicity
  • GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials
  • GB/Z 16886.22-2022 Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
  • GB/T 16886.18-2011 Biological evaluation of medical devices—Part 18:Chemical characterization of materials
  • GB/T 16886.19-2011 Biological evaluation of medical devices—Part 19:Physico-chemical,morphological and topographical characterization of materials
  • GB/T 16886.20-2015 Biological evaluation of medical devices―Part 20:Principles and methods for immunotoxicology testing of medical devices
  • GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2:Animal welfare requirements
  • GB/T 16886.1-2001 Biological evaluation of medical devices--Part 1:Evaluation and testing
  • GB/T 16886.2-2011 Biological evaluation of medical devices—Part 2:Animal welfare requirements
  • GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process
  • GB/T 16886.5-2003 Biological evaluation of medical devices - Part 5: Test for in vitro cytotoxicity
  • GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals
  • GB/T 16886.10-2000 Biological evaluation of medical devices-Part 10:Tests for irritation and sensitization
  • GB/T 16886.13-2001 Biogical evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • GB/T 16886.23-2023 Biological evaluation of medical devices—Part 23: Tests for irritation
  • GB/T 16886.1-2011 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

Professional Standard - Medicine

  • YY/T 0268-2008 Dentistry - Biological evaluation of medical devices used in dentistry Part1: Evaluation and test
  • YY/T 0127.11-2014 Biological evaluation of medical devices used in dentistry―Part 11:Pulp capping test
  • YY/T 0127.4-2023 Biological evaluation of medical devices used in dentistry-Part 4: Bone implant test
  • YY/T 1295-2015 Biological evaluation of medical devices―Nanomaterial:Endotoxin test
  • YY/T 1912-2023 Biological evaluation and testing of medical devices for soft tissue regeneration
  • YY/T 0127.5-2014 Biological evaluation of medical devices used in dentistry―Part 5:Inhalation toxicity test
  • YY/T 1815-2022 Biological evaluation of medical devices-Application for the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • YY/T 1266-2015 Evaluation of materials of medical device subject to hydrogen peroxide sterilization

Group Standards of the People's Republic of China

  • T/CSYLQX 0001-2021 Standards for Credit Evaluation of Medical Device Operating Enterprises
  • T/CAMDI 033-2020 Guide for biological evaluation of packaging materials for medical devices
  • T/SXS 129-2023 Medical device enterprise management credit evaluation standards
  • T/CAMDI 034-2020 Biological evaluation of medical devices Medical catheter with hydrophilic polymer coating:Sample preparation
  • T/CSBME 009-2019 Quality evaluation method of cybersecurity in medical devices

Jiangsu Provincial Standard of the People's Republic of China

  • DB3212/T 1065-2021 Standards for Quality Evaluation of Medical Devices Used in Medical Institutions

国家食品药品监督管理局

  • YY/T 1512-2017 Biological evaluation of medical devices—Guidance on the conduct of biological evaluation within a risk management process
  • YY/T 1532-2017 Biological evaluation of medical devices—Nanomaterials—Hemolysis test

中华人民共和国国家质量监督检验检疫总局、中国国家标准化管理委员会

  • GB/T 16886.13-2017 Biological evaluation of medical devices-Part 13:Identification and quantification of degradation products from polymeric medical devices

国家市场监督管理总局、中国国家标准化管理委员会

  • GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process
  • GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11:Tests for systemic toxicity

Professional Standard - Agriculture

  • GB/T 16886.10-2024 Biological evaluation of medical devices—Part 10:Tests for skin sensitization

Henan Provincial Standard of the People's Republic of China

  • DB41/T 2320-2022 Medical device adverse event reporting and evaluation specification

International Organization for Standardization (ISO)

  • ISO/CD 10993-1.2:2023 Biological evaluation of medical devices
  • ISO 10993-18:2020 Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process
  • ISO 10993-1:1997 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • ISO 10993-1:2003 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • ISO/TR 15499:2016 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO 10993-13:1998 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
  • ISO 10993-2:2022 Biological evaluation of medical devices — Part 2: Animal welfare requirements
  • ISO 10993-2:1992 Biological evaluation of medical devices; part 2: animal welfare requirements
  • ISO 10993-10:2021 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
  • ISO 10993-2:2006 Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • ISO 10993-11:1993 Biological evaluation of medical devices; part 11: tests for systemic toxicity
  • ISO/TS 10993-19:2020 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
  • ISO/TR 15499:2012 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices — Part 1: General requirements
  • ISO 10993-14:2001 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
  • ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • ISO 10993-1:2009/Cor 11:2010 Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
  • ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
  • ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

SCC

  • BS EN ISO 10993-18:2005 Biological evaluation of medical devices-Chemical characterization of materials
  • BS EN ISO 10993-18:2009 Biological evaluation of medical devices-Chemical characterization of materials
  • BS EN ISO 10993-1:1998 Biological evaluation of medical devices-Evaluation and testing
  • DANSK DS/ISO 10993-17:2023 Biological evaluation of medical devices – Part 17: Toxicological risk assessment of medical device constituents
  • AAMI/ISO 10993-1:2003 Biological Evaluation of Medical Devices Part 1: Evaluation and Testing
  • CAN/CSA-ISO 10993-1-01:2001 Biological evaluation of medical devices - Part 1: Evaluation and Testing
  • DANSK DS/EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • BS EN 30993-1:1994 Biological evaluation of medical devices-Guidance on selection of tests
  • BS EN ISO 10993-11:1996 Biological evaluation of medical devices-Tests for systemic toxicity
  • BS EN ISO 10993-11:2006 Biological evaluation of medical devices-Tests for systemic toxicity
  • BS EN ISO 10993-2:1998 Biological evaluation of medical devices-Animal welfare requirements
  • DANSK DS/ISO/TS 10993-20:2006 Biological evaluation of medical devices - Part 20: Principles and methods for immunotoxicology testing of medical devices
  • SN-ISO/TS 10993-20:2006 Biological evaluation of medical devices — Part 20: Principles and methods for immunotoxicology testing of medical devices
  • AS ISO 10993.10:2002 Biological evaluation of medical devices - Tests for irritation and sensitization
  • BS EN ISO 10993-13:2009 Biological evaluation of medical devices-Identification and quantification of degradation products from polymeric medical devices
  • BS PD ISO/TS 21726:2019 Biological evaluation of medical devices. Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • DANSK DS/ISO/TS 21726:2019 Biological evaluation of medical devices – Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • DIN EN ISO 10993-17 E:2021 Draft Document – Biological evaluation of medical devices – Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021); German and English version prEN ISO 10993-17:2021
  • UNE-EN ISO 10993-1:2004 Biological evaluation of medical devices - Part 1: Evaluation and testing (ISO 10993-1:2003)
  • BS PD ISO/TR 10993-22:2017 Biological evaluation of medical devices-Guidance on nanomaterials
  • BS DD ISO/TS 10993-19:2006 Biological evaluation of medical devices-Physico-chemical, morphological and topographical characterization of materials
  • BS PD ISO/TS 10993-19:2020 Biological evaluation of medical devices-Physico-chemical, morphological and topographical characterization of materials
  • NS-EN ISO 10993-1:1997 Biological evaluation of medical devices — Part 1: Evaluation and testing (ISO 10993-1:1997)
  • 08/30156451 DC BS EN ISO 10993-13. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
  • UNE-EN ISO 10993-13:2000 BIOLOGICAL EVALUATION OF MEDICAL DEVICES. PART 13: IDENTIFICATION AND QUANTIFICATION OF DEGRADATION PRODUCTS FROM POLYMERIC MEDICAL DEVICES (ISO 10993-13:1998)
  • DANSK DS/EN 13612/AC:2003 Performance evaluation of in vitro diagnostic medical devices
  • NS-EN ISO 10993-1:2003 Biological evaluation of medical devices — Part 1: Evaluation and testing (ISO 10993-1:2003)
  • NS-EN ISO 10993-1:2009 Biological evaluation of medical devices — Part 1: Evaluation and testing (ISO 10993-1:2003)
  • BS EN ISO 10993-12:2009 Biological evaluation of medical devices-Sample preparation and reference materials
  • AS ISO 10993.12:2002 Biological evaluation of medical devices - Sample preparation and reference materials
  • BS EN 30993-6:1995 Biological evaluation of medical devices-Tests for local effects after implantation
  • NS-EN ISO 10993-18:2005 Biological evaluation of medical devices — Part 18: Chemical characterization of materials (ISO 10993-18:2005)
  • DANSK DS/EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices
  • NS-EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices
  • NS-EN ISO 10993-18:2009 Biological evaluation of medical devices — Part 18: Chemical characterization of materials (ISO 10993-18:2005)
  • BS EN ISO 10993-7:1996 Biological evaluation of medical devices-Ethylene oxide sterilization residuals
  • BS EN ISO 10993-12:1997 Biological evaluation of medical devices-Sample preparation and reference materials
  • BS EN ISO 10993-10:1996 Biological evaluation of medical devices-Tests for irritation and sensitization
  • UNE-EN ISO 10993-18:2006 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005)
  • BS EN ISO 10993-6:2007 Biological evaluation of medical devices-Tests for local effects after implantation
  • DANSK DS/EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • AAMI/ISO 10993-16:1997(R2009) Biological evaluation of medical devices Part 16: Toxicokinetic study design for degradation products and leachables from medical devices
  • DIN EN ISO 10993-1/A1 E:2009 Draft Document - Biological evaluation of medical devices - Part 1: Evaluation and testing (ISO 10993-1:2003); English version FprEN ISO 10993-1:2009, Amendment 1
  • CAN/CSA-ISO 10993-13-00:2000 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • CAN/CSA-ISO 10993.2-1997(R2006) Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • CAN/CSA-ISO 10993.11-1998(R2002) Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • AAMI/ISO TIR15499:2012 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • BS 5736-8:1984 Evaluation of medical devices for biological hazards-Method of test for skin irritation of solid medical devices
  • CAN/CSA-ISO 10993.11-1998(C2002) Biological evaluation of medical devices - Part 11: Systemic toxicity testing
  • AAMI/ISO 10993-11:2017 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • CAN/CSA-ISO 10993-1-98:1998 Biological evaluation of medical devices - Part 1: Guidelines for the selection of tests
  • DANSK DS/ISO 10993-10:2023 Biological evaluation of medical devices – Part 10: Tests for skin sensitization
  • AAMI/ISO 10993-2:1993 Biological Evaluation of Medical Devices - Part 2: Animal Protection Requirements
  • BS PD ISO/TR 10993-55:2023 Biological evaluation of medical devices-Interlaboratory study on cytotoxicity
  • DANSK DS/ISO 10993-2:2022 Biological evaluation of medical devices – Part 2: Animal welfare requirements
  • DANSK DS/EN ISO 10993-11:2009 Biological evaluation of medical devices – Part 11: Tests for systemic toxicity
  • BS PD ISO/TR 10993-33:2015 Biological evaluation of medical devices-Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
  • DANSK DS/ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation
  • SN-ISO/TR 15499:2012 Biological evaluation of medical devices — Guidance on the conduct of biological evaluation within a risk management process
  • AENOR UNE-EN 13612/AC:1970 Performance evaluation of in vitro diagnostic medical devices.
  • AENOR UNE-EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices.
  • DANSK DS/ISO/TR 15499:2016 Biological evaluation of medical devices – Guidance on the conduct of biological evaluation within a risk management process
  • CAN/CSA-ISO 10993.2-1997(C2006) Biological evaluation of medical devices - Part 2: Animal protection requirements
  • BS EN 30993-5:1994 Biological evaluation of medical devices-Tests for cytotoxicity, in vitro methods
  • SN-ISO/TS 10993-19:2020 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
  • BS 5736-7:1983 Evaluation of medical devices for biological hazards-Method of test for skin irritation of extracts from medical devices
  • SN-ISO/TS 10993-19:2006 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
  • DANSK DS/EN ISO 10993-2:2006 Biological evaluation of medical devices – Part 2: Animal welfare requirements
  • ADA 41-2020 Evaluation of Biocompatibility of Medical Devices Used in Dentistry
  • DANSK DS/ISO/TR 10993-22:2021 Biological evaluation of medical devices – Part 22: Guidance on nanomaterials
  • BS 5736-4:1981 Evaluation of medical devices for biological hazards-Method of test for intracutaneous reactivity of extracts from medical devices
  • ADA 41-2015 Evaluation of Biocompatibility of Medical Devices Used in Dentistry
  • DANSK DS/ISO/TS 10993-19:2020 Biological evaluation of medical devices – Part 19: Physico-chemical, morphological and topographical characterization of materials
  • NS-EN ISO 10993-13:1998 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymers medical devices (ISO 10993-13:1998)
  • AAMI/ISO 10993-5:1999 Biological evaluation of medical devices - Part 5: Tests for In Vitro Cytotoxicity
  • DANSK DS/ISO 10993-18/AMD 1:2020 Biologisk vurdering af medicinsk udstyr – Del 18: Kemisk karakterisering af materialer til medicinsk udstyr inden for rammerne af en risikostyringsproces
  • DANSK DS/ISO 10993-18:2020 Biologisk vurdering af medicinsk udstyr – Del 18: Kemisk karakterisering af materialer til medicinsk udstyr inden for rammerne af en risikostyringsproces
  • BS 5736-10:1988 Evaluation of medical devices for biological hazards-Method of test for toxicity to cells in culture of extracts from medical devices
  • AS ISO 10993.4:2002 Biological evaluation of medical devices - Selection of tests for interactions with blood
  • BS EN 30993-4:1994 Biological evaluation of medical devices-Selection of tests for interactions with blood
  • BS 5736-1:1989 Evaluation of medical devices for biological hazards-Guide for the selection of biological methods of test
  • NS-EN ISO 10993-13:2009 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)
  • CAN/CSA-ISO 10993-5-01:2001 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • BS 5736-1:1979 Evaluation of medical devices for biological hazards-Guide for the selection of biological methods of test
  • DANSK DS/EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • AENOR UNE-EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)
  • NS-EN ISO 10993-13:2010 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)
  • DANSK DS/ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices – Part 1: General requirements
  • DANSK DS/ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
  • UNE-EN ISO 10993-13:2009 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)
  • AAMI/ISO TIR10993-19:2006 Biological evaluation of medical devices - Part 19: Physio-chemical, morphological and topographical characterization of materials [Historical]
  • CAN/CSA-ISO 10993.7-1998(R2007) Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • BS 5736-3:1981 Evaluation of medical devices for biological hazards-Method of test for systemic toxicity; assessment of acute toxicity of extracts from medical devices
  • BS PD ISO/TR 15499:2012 Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process

British Standards Institution (BSI)

  • BS EN ISO 10993-17:2023 Biological evaluation of medical devices - Toxicological risk assessment of medical device constituents
  • DD ISO/TS 10993-20:2006 Biological evaluation of medical devices. Principles and methods for immunotoxicology testing of medical devices
  • 21/30379304 DC BS EN ISO 10993-17. Biological evaluation of medical devices - Part 17. Toxicological risk assessment of medical device constituents
  • BS EN ISO 10993-2:2022 Biological evaluation of medical devices - Animal welfare requirements
  • PD ISO/TR 10993-22:2017 Biological evaluation of medical devices. Guidance on nanomaterials
  • BS EN ISO 10993-13:2010 Biological evaluation of medical devices. Part 13: Identification and quantification of degradation products from polymeric medical devices
  • BS EN ISO 10993-10:2023 Biological evaluation of medical devices. Tests for skin sensitization
  • PD ISO/TS 21726:2019 Biological evaluation of medical devices. Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • 18/30358832 DC BS EN ISO 10993-18. Biological evaluation of medical devices. Part 18. Chemical characterization of medical device materials within a risk management process
  • PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
  • BS PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
  • PD ISO/TS 10993-19:2020 Biological evaluation of medical devices. Physico-chemical, morphological and topographical characterization of materials
  • 24/30482502 DC BS EN ISO 10993-17:2023/Amd 1 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents — Amendment
  • BS EN ISO 10993-18:2020+A1:2023 Biological evaluation of medical devices - Chemical characterization of medical device materials within a risk management process
  • ISO 10993-18:2020/Amd.1:2022 Biological evaluation of medical devices - Chemical characterization of medical device materials within a risk management process
  • BS EN ISO 10993-1:2003 Biological evaluation of medical devices - Evaluation and testing
  • BS EN ISO 10993-12:2021 Biological evaluation of medical devices. Sample preparation and reference materials
  • BS EN 29073-3:1992 Biological evaluation of medical devices. Framework for identification and quantification of potential degradation products
  • BS EN ISO 10993-7:2008+A1:2022 Biological evaluation of medical devices. Ethylene oxide sterilization residuals
  • BS EN ISO 10993-12:2012 Biological evaluation of medical devices. Sample preparation and reference materials
  • BS EN ISO 10993-11:2018(2022) Biological evaluation of medical devices Part 11 : Tests for systemic toxicity
  • BS EN ISO 10993-6:2016 Biological evaluation of medical devices. Tests for local effects after implantation
  • BS EN ISO 10993-9:2021 Biological evaluation of medical devices. Framework for identification and quantification of potential degradation products
  • BS EN ISO 10993-18:2020 Biological evaluation of medical devices Part 18 : Chemical characterization of medical device materials within a risk management process
  • BS EN ISO 10993-11:2018 Biological evaluation of medical devices. Tests for systemic toxicity
  • BS EN ISO 10993-6:2009 Biological evaluation of medical devices. Tests for local effects after implantation
  • BS PD ISO/TR 15499:2016 Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
  • BS EN ISO 10993-1:2020 Biological evaluation of medical devices. Evaluation and testing within a risk management process
  • PD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices. Guidance for absorbable implants
  • PD ISO/TR 10993-55:2023 Biological evaluation of medical devices. Interlaboratory study on cytotoxicity
  • 24/30453873 DC BS EN ISO 10993-6 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation

RU-GOST R

  • GOST ISO 10993-1-2011 Medical devices. Biological evaluation of medical devices. Part 1. Evaluation and testing
  • GOST ISO 10993-18-2011 Medical devices. Biological evaluation of medical devices. Part 18. Chemical characterization of materials
  • GOST ISO 10993-13-2011 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
  • GOST ISO 10993-11-2011 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic toxicity
  • GOST R ISO 10993-11-1999 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic to xicity
  • GOST ISO/TS 10993-20-2011 Medical devices. Biological evaluation of medical devices. Part 20. Principles and methods for immunotoxicology testing of medical devices
  • GOST ISO 10993-14-2011 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
  • GOST R ISO 10993-14-2001 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
  • GOST R ISO 10993-10-1999 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and sensitization
  • GOST ISO/TS 10993-19-2011 Medical devices. Biological evaluation of medical devices. Part 19. Tests physico-chemical, morphological and topographical characterization of materials
  • GOST ISO 10993-5-2011 Medical devices. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity
  • GOST ISO 10993-7-2016 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST ISO 10993-13-2016 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
  • GOST ISO 10993-9-2011 Medical devices. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
  • GOST ISO 10993-7-2011 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST ISO 10993-6-2011 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
  • GOST ISO 10993-12-2011 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and control materials
  • GOST R ISO 10993-6-1999 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
  • GOST R ISO 10993-12-1999 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials
  • GOST ISO 10993-15-2011 Medical devices. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys
  • GOST R ISO 10993-15-2001 Medical devices. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys
  • GOST ISO 10993-10-2011 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and delayed-type hypersensitivity
  • GOST ISO 10993-17-2011 Medical devices. Biological evaluation of medical devices. Part 17. Establishment of allowable limits for leachable substances
  • GOST ISO 10993-4-2011 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
  • GOST ISO 10993-9-2015 Medical devices. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
  • GOST R ISO 10993.7-1999 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST ISO 10993-16-2016 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST ISO 10993-3-2011 Medical devices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GOST R ISO 10993.5-1999 Medical devices. Biological evaluation of medical devices. Part 5. Tests for cytotoxicity: in vitro methods
  • GOST ISO 10993-16-2011 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST R ISO 10993.4-1999 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood

Standard Association of Australia (SAA)

  • ISO 10993-17:2023 Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents
  • AS ISO 10993.11:2002/Amdt 1:2005 Biological evaluation of medical devices Systemic toxicity testing
  • AS ISO 10993.17:2004 Biological evaluation of medical devices - Establishment of allowable limits for leachable substances

German Institute for Standardization

  • DIN EN ISO 10993-17:2021-12 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021); German and English version prEN ISO 10993-17:2021 / Note: Date of issue 2021-11-12*Intended as replacement for DIN...
  • DIN EN ISO 10993-17:2024-02 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023); German version EN ISO 10993-17:2023
  • DIN EN 13612:2002-08 Performance evaluation of in vitro diagnostic medical devices; German version EN 13612:2002, German and English texts
  • DIN EN ISO 10993-2:2023-02 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022); German version EN ISO 10993-2:2022
  • DIN EN ISO 10993-11:2018-09 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017); German version EN ISO 10993-11:2018
  • DIN EN ISO 10993-10:2023-04 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021); German version EN ISO 10993-10:2023
  • DIN EN ISO 10993-18/A1:2021-10 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/DAM 1:2021); German and English version...
  • DIN EN ISO 10993-5:2009-10 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009); German version EN ISO 10993-5:2009
  • DIN EN ISO 10993-13:2010-11 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010); German version EN ISO 10993-13:2010
  • DIN EN ISO 10993-1:2010 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management system (ISO 10993-1:2009); German version EN ISO 10993-1:2009

VN-TCVN

  • TCVN 7391-18-2007 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
  • TCVN 7391-1-2004 Biological evaluation of medical devices.Part 1: Evaluation and testing
  • TCVN 7391-2-2005 Biological evaluation of medical devices.Part 2: Animal welfare requirements
  • TCVN 7391-11-2007 Biological evaluation of medical devices.Part 11: Tests for systemic toxicity
  • TCVN 7391-14-2007 Biological evaluation of medical devices.Part 14: Identification and quantification of degradation products from ceramics
  • TCVN 7391-5-2005 Biological evaluation of medical devices.Part 5: Tests for in vitro cytotoxicity
  • TCVN 7391-7-2004 Biological evaluation of medial devices.Part 7: Etylen oxide sterilization residuals

TH-TISI

  • TIS 2395.18-2008 Biological evaluation of medical devices.part 18: chemical characterization of materials
  • TIS 2395.1-2008 Biological evaluation of medical devices.part 1: evaluation and testing
  • TIS 2395.13-2008 Biological evaluation of medical devices.part 13: identification and quantification of degradation products from polymeric medical devices
  • TIS 2395.11-2008 Biological evaluation of medical devices.part 11: tests for systemic toxicity
  • TIS 2395.2-2008 Biological evaluation of medical devices.part 2: animal welfare requirements
  • TIS 2395.5-2008 Biological evaluation of medical devices.part 5: tests for in vitro cytotoxicity
  • TIS 2395.6-2008 Biological evaluation of medical devices.part 6: tests for local effects after implantation
  • TIS 2395.12-2008 Biological evaluation of medical devices.part 12: sample preparation and reference materials

Korean Agency for Technology and Standards (KATS)

  • KS P ISO 10993-18:2021 Biological evaluation of medical devices —Part 18: Chemical characterization of medical device materials within a risk management process
  • KS P ISO 10993-18-2009(2019) Biological evaluation of medical devices-Part 18:Chemical characterization of materials
  • KS P ISO 10993-20-2019 Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
  • KS P ISO 10993-20-2009(2019) Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
  • KS P ISO TS 21726-2023 Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • KS P ISO TS 20993-2020 Biological evaluation of medical devices-Guidance on a risk-management process
  • KS P ISO TS 20993-2009(2014) Biological evaluation of medical devices-Guidance on a risk-management process
  • KS P ISO 10993-13-2023 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices
  • KS P ISO 10993-2-2010(2021) Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO TR 15499-2021 Biological evaluation of medical devices — Guidance on the conduct of biological evaluation within a risk management process
  • KS P ISO 10993-11-2007(2017) Biological evaluation of medical devices-Part 11:Tests for systemic toxicity
  • KS P ISO 10993-2-2010(2016) Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-2-2021 Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-19-2009(2019) Biological evaluation of medical devices-Part 19:Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO TS 10993-19:2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-11:2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
  • KS P ISO 10993-5-2023 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
  • KS P ISO TS 37137-1-2023 Biological evaluation of absorbable medical devices — Part 1: General requirements

GSO

  • GSO ISO 10993-18:2016 Biological evaluation of medical devices -- Part 18: Chemical characterization of materials
  • BH GSO ISO 10993-18:2017 Biological evaluation of medical devices -- Part 18: Chemical characterization of materials
  • OS GSO ISO 10993-18:2016 Biological evaluation of medical devices -- Part 18: Chemical characterization of materials
  • GSO ISO/TS 10993-20:2016 Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices
  • OS GSO ISO/TS 10993-20:2016 Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices
  • BH GSO ISO/TS 10993-20:2017 Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices
  • GSO ISO/TS 21726:2021 Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • BH GSO ISO/TS 21726:2022 Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • GSO ISO 10993-23:2024 Biological evaluation of medical devices — Part 23: Tests for irritation
  • OS GSO ISO/TR 15499:2016 Biological evaluation of medical devices -- Guidance on the conduct of biological evaluation within a risk management process
  • GSO ISO/TR 15499:2016 Biological evaluation of medical devices -- Guidance on the conduct of biological evaluation within a risk management process
  • OS GSO ISO 10993-13:2016 Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices
  • BH GSO ISO 10993-13:2017 Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices
  • GSO ISO 10993-13:2016 Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices
  • GSO ISO 10993-11:2015 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity
  • OS GSO ISO/TS 10993-19:2016 Biological evaluation of medical devices -- Part 19: Physico-chemical, morphological and topographical characterization of materials
  • GSO ISO/TR 10993-22:2021 Biological evaluation of medical devices — Part 22: Guidance on nanomaterials
  • BH GSO ISO 10993-2:2017 Biological evaluation of medical devices -- Part 2: Animal welfare requirements
  • OS GSO ISO 10993-11:2015 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity
  • BH GSO ISO/TR 10993-22:2022 Biological evaluation of medical devices — Part 22: Guidance on nanomaterials
  • BH GSO ISO 10993-11:2017 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity
  • GSO ISO/TS 10993-19:2016 Biological evaluation of medical devices -- Part 19: Physico-chemical, morphological and topographical characterization of materials
  • BH GSO ISO/TS 10993-19:2017 Biological evaluation of medical devices -- Part 19: Physico-chemical, morphological and topographical characterization of materials
  • GSO ISO/TR 37137:2024 Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants
  • BH GSO ISO/TS 37137-1:2023 Biological evaluation of absorbable medical devices — Part 1: General requirements
  • BH GSO ISO 10993-5:2017 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
  • GSO ISO 10993-5:2015 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
  • GSO ISO/TS 37137-1:2023 Biological evaluation of absorbable medical devices — Part 1: General requirements

IT-UNI

  • UNI EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process
  • UNI EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
  • UNI EN ISO 10993-1:2021 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

KR-KS

  • KS P ISO 10993-18-2021 Biological evaluation of medical devices —Part 18: Chemical characterization of medical device materials within a risk management process
  • KS P ISO 10993-13-2018(2023) Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices
  • KS P ISO 10993-23-2022 Biological evaluation of medical devices — Part 23: Tests for irritation
  • KS P ISO 10993-10-2022 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
  • KS P ISO 10993-11-2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
  • KS P ISO TS 10993-19-2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-5-2018(2023) Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
  • KS P ISO 10993-6-2018(2023) Biological evaluation of medical devices — Part 6: Tests for local effects after implantation

Association Francaise de Normalisation

Japanese Industrial Standards Committee (JISC)

  • JIS T 0993-1:2005 Biological evaluation of medical devices -- Part 1: Evaluation and testing
  • JIS T 0993-1:2012 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process

CEN - European Committee for Standardization

  • EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • EN ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • EN ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-14:2009 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
  • EN ISO 10993-14:2001 Biological Evaluation of Medical Devices - Part 14: Identification and Quantification of Degradation Products from Ceramics

DIN

  • DIN EN ISO 10993-17:2024 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023)
  • DIN EN ISO 10993-13:1999 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)
  • DIN EN ISO 10993-13:2009 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)

European Committee for Standardization (CEN)

  • EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • FprEN ISO 10993-17 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/FDIS 10993-17:2023)
  • EN ISO 10993-17:2023 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023)
  • EN ISO 10993-18:2020/prA1 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • EN ISO 10993-18:2020/prA1:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/DAM 1:2021)
  • EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-11:1995 Biological Evaluation of Medical Devices - Part 11: Tests for Systemic Toxicity (ISO 10993-11 : 1993)

GOST

  • GOST R ISO/TS 10993-20-2009 Medical devices. Biological evaluation of medical devices. Part 20. Principles and methods for immunotoxicology testing of medical devices
  • GOST R ISO/TS 10993-19-2009 Medical devices. Biological evaluation of medical devices. Part 19. Tests physico-chemical, morphological and topographical characterization of materials

American National Standards Institute (ANSI)

AT-ON

  • OENORM EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • OENORM EN ISO 10993-18/A1:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020/DAM 1:2021) (Amendment)

PL-PKN

  • PN-EN ISO 10993-18-2020-11 E Biological evaluation of medical devices -- Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • PN-EN ISO 10993-23-2021-08 E Biological evaluation of medical devices -- Part 23: Tests for irritation (ISO 10993-23:2021)

CH-SNV

  • SN EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)

GOSTR

  • GOST ISO/TR 10993-22-2020 Medical devices. Biological evaluation of medical devices. Part 22. Guidance on nanomaterials
  • GOST R EN 13612-2010 Performance evaluation of in vitro diagnostic medical devices
  • GOST ISO 10993-4-2020 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
  • GOST ISO/TR 10993-33-2018 Medical levices. Biological evaluation of medical devices. Part 33. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
  • GOST ISO 10993-3-2018 Medical levices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicit
  • GOST R ISO 10993-2-2009 Standardization in the Russian Federation. Medical devices. Biological evaluation of medical devices. Part 2. Animal welfare requirements
  • GOST R ISO 7405-2011 Dentistry. Evaluation of biocompatibility of medical devices used in dentistry

AENOR

  • UNE-EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005)
  • UNE-EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices.
  • UNE-EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)

Danish Standards Foundation

Canadian Standards Association (CSA)

ES-UNE

  • UNE-EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • UNE-EN 13612/AC:2003 Performance evaluation of in vitro diagnostic medical devices.
  • UNE-EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • UNE-EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017)
  • UNE-EN ISO 10993-12:2022 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)

US-AAMI

  • ANSI/AAMI/ISO TIR15499:2012 Biological evaluation of medical devices - Guideance on the conduct of biological evaluation within a risk management process
  • ANSI/AAMI/ISO 10993-1:2009 Biological evaluation of medical devices - Part 1:Evaluation and testing within a risk management process

PH-BPS